Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2000
03/09/2000WO2000012752A1 Mechanical turing machine designed for molecular implementation
03/09/2000WO2000012751A1 Method for testing anti-bacterial attachment compositions
03/09/2000WO2000012750A1 Detection system for coliforms
03/09/2000WO2000012749A1 Method for screening srebp pathway-specific inhibitors
03/09/2000WO2000012737A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000WO2000012736A2 A new method of identifying non-host plant disease resistance genes
03/09/2000WO2000012735A2 Transgene assay using stable agrobacterium rhizogenes transformation
03/09/2000WO2000012727A1 Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity
03/09/2000WO2000012726A2 Rationally designed heparinases derived from heparinase i and ii
03/09/2000WO2000012723A1 A novel human lysozyme gene, its encoding polypeptide and the method for preparing them
03/09/2000WO2000012717A1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them
03/09/2000WO2000012710A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
03/09/2000WO2000012709A2 Phelix: a testis-specific protein expressed in cancer
03/09/2000WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
03/09/2000WO2000012705A2 Methods for improving the function of heterologous g protein-coupled receptors
03/09/2000WO2000012704A2 Enhanced functional expression of g protein-coupled receptors
03/09/2000WO2000012703A2 Protein transport-associated molecules
03/09/2000WO2000012702A2 Human genes differentially expressed in colorectal cancer
03/09/2000WO2000012696A1 Cell specific promoters of uncoupling protein 3
03/09/2000WO2000012689A1 Polypeptides and polynucleotides from coagulase-negative staphylococci
03/09/2000WO2000012685A2 Genes associated with neurotransmitter processing
03/09/2000WO2000012679A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000WO2000012678A2 Staphylococcus aureus genes and polypeptides
03/09/2000WO2000012675A1 Self-contained device integrating nucleic acid extraction, amplification and detection
03/09/2000WO2000012674A1 Card for counting and characterising micro-organisms
03/09/2000WO2000012552A1 MAMMARY-SPECIFIC TRANSCRIPTION FACTOR BrEts
03/09/2000WO2000012551A1 HUMAN LATENT TRANSFORMING GROWTH FACTOR-β BINDING PROTEIN 3
03/09/2000WO2000012549A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
03/09/2000WO2000012546A1 MAMMALIAN elk POTASSIUM CHANNEL GENES
03/09/2000WO2000012544A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
03/09/2000WO2000012531A1 Ratc
03/09/2000WO2000012529A1 Sperm antigens associated with infertility
03/09/2000WO2000012525A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000WO2000012191A1 Fraction collection system and method
03/09/2000WO2000012175A2 Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
03/09/2000WO2000012139A1 Hypoxia regulated genes
03/09/2000WO2000012123A2 Method and measuring device for determining a plurality of analytes in a sample
03/09/2000WO2000012111A2 Selective treatment of endothelial somatostatin receptors
03/09/2000WO2000012105A1 RAMP2a: RECEPTOR ACTIVITY MODIFYING PROTEIN-2a
03/09/2000WO2000001829A3 Formaldehyde dehydrogenase genes from methylotrophic yeasts
03/09/2000WO2000000607B1 A nucleic acid encoding a retinoblastoma binding protein (rbp-7) and polymorphic markers associated with said nucleic acid
03/09/2000WO1999067641A3 Decoding of array sensors with microspheres
03/09/2000WO1999067402A3 Methods to screen herbicidal compounds utilizing air synthetase from arabidopsis thaliana
03/09/2000WO1999065847A3 Malodorant compositions, related non-lethal weapon systems, and methods of their use
03/09/2000WO1999062548A9 Methods and compositions for diagnosing tauopathies
03/09/2000WO1999062333A9 Bacteriophage-based transgenic fish for mutation detection
03/09/2000WO1999060017A3 Human tumour-derived polypeptide hormone phosphatonin
03/09/2000WO1999058712A3 Detection of genes
03/09/2000WO1999057310A3 Instrument for analysis and diagnostics
03/09/2000WO1999057306A3 Method for diagnosing a vascular condition
03/09/2000WO1999055915A3 IDENTIFICATION OF POLYMORPHISMS IN THE PCTG4 REGION OF Xq13
03/09/2000WO1999055873A3 Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
03/09/2000WO1999043845A3 Polynucleotide sequencing method and kits therefor
03/09/2000WO1999020260A3 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
03/09/2000DE19840897A1 Assay for detecting the factor V disease mutation comprises a polymerase chain reaction using a reporter/quencher-labeled probe having a defined nucleotide sequence
03/09/2000DE19840731A1 Zwei Farben Differential Display als Verfahren zur Detektion regulierter Gene Two colors as differential display method for detecting regulated genes
03/09/2000DE19840545A1 Identifying protease substrates and inhibitors, potentially useful for treating tumor invasion, comprises reacting a test sample with immobilized substrate containing fluorescent donor-acceptor pair
03/09/2000DE19840531A1 Mit Nukleinsäuren beschichtete Reaktionsräume, Verfahren zu ihrer Herstellung und ihre Verwendung Coated with nucleic acids reaction chambers, process for their preparation and their use
03/09/2000DE19840028A1 Nucleinsäuremoleküle codierend Enzyme, die Fructosyltransferaseaktivität besitzen, und deren Verwendung Nucleic acid molecules encoding enzymes having fructosyltransferase activity which, and their use
03/09/2000DE19839573A1 Identifying organisms comprises comparing electrophoretic mobilities of nucleic acid amplification products with standards, useful e.g. for detecting microorganisms in foodstuffs and waste water, and for diagnostic or forensic purposes
03/09/2000DE19838429A1 Assay method, especially for microbiological analytes, comprises using reference material to verify correct functioning of the detection system
03/09/2000DE19818680C1 A DNA double strand break repair protein, Nibrin, and related DNA useful for diagnosis and therapy of Nijmegen Breakage Syndrome and other diseases influenced by DNA-double-strand break repair
03/09/2000CA2344591A1 Methods for improving the function of heterologous g protein-coupled receptors
03/09/2000CA2343046A1 Enhanced functional expression of g protein-coupled receptors
03/09/2000CA2342581A1 Reaction chambers coated with defined concentrations of nucleic acids, method for the production and use thereof
03/09/2000CA2341896A1 Support for a method for determining an analyte and a method for producing the support
03/09/2000CA2341894A1 Method and device for preparing and/or analyzing biochemical reaction carriers
03/09/2000CA2341766A1 Mammalian elk potassium channel genes
03/09/2000CA2341705A1 Sequences characteristic of hypoxia-regulated gene transcription
03/09/2000CA2341687A1 Self-contained device integrating nucleic acid extraction, amplification and detection
03/09/2000CA2341627A1 Method for assessing the relative purity of viral gene transfer vector stocks
03/09/2000CA2341619A1 Methods and materials for diagnosing unstable angina
03/09/2000CA2341518A1 Hypoxia regulated genes
03/09/2000CA2341412A1 Rationally designed heparinases derived from heparinase i and ii
03/09/2000CA2341411A1 Method for testing anti-bacterial attachment compositions
03/09/2000CA2341324A1 Transgene assay using stable agrobacterium rhizogenes transformation
03/09/2000CA2341311A1 Staphylococcus aureus genes and polypeptides
03/09/2000CA2341308A1 Human latent transforming growth factor-.beta. binding protein 3
03/09/2000CA2341157A1 Stable isotope metabolic labeling for analysis of biopolymers
03/09/2000CA2341148A1 Human membrane channel proteins
03/09/2000CA2341142A1 A novel method of diagnosing, monitoring, staging, imaging and treating various cancers
03/09/2000CA2341064A1 Novel ubiquitin ligases as therapeutic targets
03/09/2000CA2341051A1 Cell specific promoters of uncoupling protein 3
03/09/2000CA2340937A1 A new method of identifying non-host plant disease resistance genes
03/09/2000CA2340885A1 Protein domains in the hepatic glycogen-targetting subunit of protein phosphatase 1 and methods of making and using the same
03/09/2000CA2340796A1 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
03/09/2000CA2340794A1 Protein transport-associated molecules
03/09/2000CA2340617A1 Genes associated with neurotransmitter processing
03/09/2000CA2340596A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
03/09/2000CA2340592A1 Phelix: a testis-specific protein expressed in cancer
03/09/2000CA2340589A1 Toxicological response markers
03/09/2000CA2339539A1 Modulating multiple lineage kinase proteins
03/09/2000CA2308309A1 Fraction collection system and method
03/09/2000CA2249657A1 Novel compounds
03/08/2000EP0984282A2 Particles having an incorporated composition comprising a chemiluminescent compound
03/08/2000EP0984281A2 A homogeneous assay for determining analyte
03/08/2000EP0984070A1 Method for identifying substances for the treatment of disorders associated with c-Jun-mediated apoptosis
03/08/2000EP0984068A2 Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0984067A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
03/08/2000EP0983795A2 Probe bearing element and method for producing the same
1 ... 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 2579 2580 2581 2582 2583 2584 2585 2586 2587 ... 3003